Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Gemtuzumab ozogamicin
open-in-new
<p>Gemtuzumab ozogamicin, sold under the brand name Mylotarg, is an <a href="/facts/Antibody-drug_conjugate/STv3FcXw">antibody-drug conjugate</a> (a drug-linked <a href="/facts/Monoclonal_antibody/4rUBWB87">monoclonal antibody</a>) that is used to treat <a href="/facts/Acute_myeloid_leukemia/jvbXzg3J">acute myeloid leukemia</a> (AML). </p><p>The most common side effects include infection, febrile neutropenia, decreased appetite, hyperglycemia, mucositis, hypoxia, hemorrhage, increased transaminase, diarrhea, nausea, and hypotension. However, the addition of gemtuzumab ozogamicin to standard chemotherapy regimens does not increase infection rates. </p>